Table 5. Dose intensity for phase I/II.

	PDI (mg m−2 week−1)		ADI (mg m−2 week−1)		RDI (mg m−2 week−1)
	CDDP	PTX	CDDP	PTX	CDDP	PTX
Phase I
Level 1	20.0	30.0	19.7	29.5	0.98	0.98
Level 2	20.0	37.5	18.5	32.6	0.93	0.87
Level 3	20.0	45.0	16.5	32.1	0.83	0.71
Level 4	20.0	52.5	17.8	36.7	0.89	0.70
Phase II
	20.0	52.5	19.2	41.6	0.96	0.79

PDI=projected dose intensity; ADI=actual dose intensity; RDI=relative dose intensity; CDDP=cisplatin; PTX=paclitaxel.